EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota

Wentai Yang, Qing Jin, Dewang Xiao, Xiang Li, Defa Huang

Frontiers in Microbiology · 18.09.2025 · 16

DOI: 10.3389/fmicb.2025.1597995 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 18.09.2025. Verfasst von Wentai Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interaction between metabolic dysfunction-associated seatotic liver disease (MASLD) and gut microbiota regulates hepatic metabolic homeostasis through the gut-liver axis, and its mechanisms involve intestinal dysbiosis (decreased bacteroidetes , increased ratio of firmicutes / proteobacteria ), bile acid metabolism reprogramming (secondary bile acids inhibit FXR signaling), short-chain fatty acid (SCFAs) deficiency, and endotoxin-mediated inflammatory activation (TLR4/NF-κB pathway). Among the intervention strategies, probiotics (such as Bifidobacteria ) improved inflammation by regulating microbiota structure and intestinal barrier function, prebiotics such as resistant starch enriched butyric acid-producing bacteria and reduced liver lipid deposition, fecal microbiota transplantation (FMT) could remodel the microbiota but needed to optimize safety, restricted fructose intake and Mediterranean diet reduced liver damage by regulating microbiota metabolism, and metabolic surgery improved fibrosis through microbiota remodeling and bile acid signaling. In the future, it is necessary to combine multi-omics technology to analyze the microbiota-host interaction network, develop precision therapies such as phage targeted clearance or engineering bacterial delivery of metabolites, and promote the clinical transformation of personalized intervention programs.

Schlagwörter

Stichwörter der Autor:innen

fecal microbiota transplantationgut microbiotagut-liver axismetabolic dysfunction-associated steatotic liver diseasemicrobial metabolitesprebioticsprobiotics

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
  • The First Clinical Medical College of Gannan Medical University, Ganzhou, China.
  • Laboratory Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Zitieren

APA

Yang, W., Jin, Q., Xiao, D., Li, X., & Huang, D. (2025). Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1597995

Vancouver

Yang W, Jin Q, Xiao D, Li X, Huang D. Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1597995

BibTeX
@article{Yang2025,
  author = {Yang, Wentai and Jin, Qing and Xiao, Dewang and Li, Xiang and Huang, Defa},
  title = {Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1597995}
}
Kostenlos starten →